August 10.2020
AVATAMED Raises US$1 Million in Seed Funding

We are pleased to announce the completion of our Seed Funding of US$1 million in March 2020.

 

We welcome Professor Pierce Chow, Senior Consultant at National Cancer Centre Singapore (NCCS), Professor Vinay Tergaonkar, Research Director at Institute of Molecular Cell Biology (IMCB) Singapore, Dr. Jae-Hoon Song, ex-President at Samsung Medical Centre, and Chung Joon, President at Solid Inc., as Board of Directors.

 

For more information of the Funding, please refer to the attached Press Release.

 

Also announced in the Press Release, in the fight against COVID-19, we launched AVATA Healthcare, www.avatahealthcare.com, to offer various infectious disease-related products to medical professionals, through our global network in the healthcare community.

August 10.2020
Attachments
AVATAMED_Seed_Funding_Press_Release_10082020.pdf
Prev
AVATAMED Signed Distribution Agreement with BioTNS for the Sales of COVID-19 RT-PCR PNA Diagnostic Kits
Next
AVATAMED and Macrogen sign MOU on joint business in personalized precision medicine services in cancer treatment